Trials / Completed
CompletedNCT00768196
Prevalence of EED and Quality of Life Evaluated by Gastroesophageal Reflux Disease (GERD)-Q in Korean GERD Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,000 (estimated)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to asses the EED symptom prevalence in Koran GERD patients with typical reflux symptom and to evaluate quality of life with the scales including Gerd Q.
Conditions
Timeline
- Start date
- 2008-09-01
- Completion
- 2009-02-01
- First posted
- 2008-10-07
- Last updated
- 2010-12-07
Locations
4 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT00768196. Inclusion in this directory is not an endorsement.